Amphastar stockholders elect three Class III directors, ratify auditor, approve say-on-pay at 2022 annual meeting

Amphastar Pharmaceuticals, Inc.

Elected directors Jack Zhang, Richard Prins, Diane Gerst; Zhang received 31,356,354 for, Prins 28,273,064, Gerst 25,594,041.
Ratified Ernst & Young as independent auditor for FY2022; 42,659,628 for, 696,578 against.
Advisory vote on executive compensation approved with 37,248,485 for, 1,247,234 against.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.